Demographical and clinical characteristics of the study cohort
| Patients (n = 174) | |
|---|---|
| AZA, azathioprine; CD, Crohn’s disease; IFX, infliximab; IS, immunosuppression; IQR, interquartile range; MTX, methotrexate; WBC, white blood cell. | |
| Values are given as n (%) unless otherwise specified. | |
| Female | 107 (61.5) |
| Mean age (range years) | 39 (18–73) |
| Mean age at first IFX (range; years) | 35 (14/72) |
| Indication for IFX | |
| Luminal CD | 138 (79) |
| Fistulising CD | 36 (21) |
| Disease location | |
| Ileitis | 36 (21) |
| Ileocolitis | 84 (48) |
| Colitis | 54 (31) |
| Concomitant IS therapy | |
| No IS | 59 (34.0) |
| AZA | 65 (37.3) |
| MTX | 50 (28.7) |
| Active smoking | 45 (25.9) |
| Median WBC baseline (IQR) | 7.800 (6.125–9.875) |